Wire
Citigroup Adjusts Price Target on IDEX to $252 From $243
IDEX (IEX) has an average rating of overweight and mean price target of $236.46, according to analysts polled by FactSet.Price: $218.56, Change: $+1.22, Percent Change: +0.56%
$IEX
$IEX
23 stories mentioning IEXUpdated 8d ago
Every FINWIRES story that references IEX, newest first.
What are analysts saying about IEX?
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
- MizuhoUpgradedOutperformPrice target$280from $210
- DA DavidsonTarget revisedPrice target$240from $230
- ArgusTarget revisedPrice target$260from $250
- BMO CapitalTarget revisedMarket PerformPrice target$251from $230
- BairdTarget revisedOutperformPrice target$274from $257
- BNP ParibasTarget revisedNeutralPrice target$215from $210
What's the latest news on IEX?
Wire
Oppenheimer Adjusts Price Target on IDEX to $242 From $230, Maintains Outperform Rating
IDEX (IEX) has an average rating of overweight and mean price target of $236.46, according to analysts polled by FactSet.Price: $219.82, Change: $+2.47, Percent Change: +1.14%
$IEX
Research
Research Alert: Idex: High-growth Market Exposure Fuels Q1 Beat
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:IEX's Q1 results significantly exceeded expectations with operating EPS of $2.00 (up 14% Y/Y) vs. consensus of $1.77, representing a solid $0.23 beat, while organic sales growth accelerated to 5% from Q4's 1%. Orders hit a record $988M (up 10%) as demand broadened across the diversified portfolio. The Health & Science Tech segment was the primary growth driver, with 17% reported and 11% organic sales growth, plus 100 bps of adjusted EBITDA margin expansion to 26.6%, underpinned by AI-driven data center power solutions demand and semiconductor applications. Management raised full-year 2026 guidance, projecting organic sales growth of 3%-4% (up from 1%-2%) and adjusted EPS of $8.35-$8.55 (up from $8.15-$8.35). While gross margin declined 40 bps to 44.9% due to unfavorable mix, adjusted EBITDA margin expanded 50 bps to 26%, as 80/20 initiatives bear fruit. In our view, the upgraded outlook reflects an improved demand backdrop across IEX's diversified end markets.
$IEX
Showing 21-23 of 23
